找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: HDL Deficiency and Atherosclerosis; G. Assmann Book 1995 Kluwer Academic Publishers 1995 Lipoprotein.atherosclerosis.cardiovascular.corona

[復(fù)制鏈接]
樓主: 宣告無效
21#
發(fā)表于 2025-3-25 03:52:23 | 只看該作者
22#
發(fā)表于 2025-3-25 09:33:50 | 只看該作者
Connection between cholesterol efflux and atherosclerosis, The two major subclasses include particles that contain both apoA-I and apoA-II (termed LpA-I, A-II) and those that contain apoA-I but not apoA-II (termed LpA-I). Apo-specific particles can be isolated by use of immunoaffinity columns with anti-apoA-I or anti-apoA-II antibody..
23#
發(fā)表于 2025-3-25 14:06:19 | 只看該作者
https://doi.org/10.1057/9781137295866 possesses arginine. The apoE2 isoform, associated with type III hyperlipoproteinaemia., differs from apoE3 only at residue 158, where it possesses cysteine. Apolipoproteins E3 and E4 bind normally to the low density lipoprotein (LDL) receptor, whereas apoE2 does not.
24#
發(fā)表于 2025-3-25 15:50:58 | 只看該作者
25#
發(fā)表于 2025-3-25 23:18:23 | 只看該作者
Book 1995on of massive scientific research, continuous transfer of the results to medical practice, community actions and population aware- ness. The death rate from coronary heart disease in the United States rose 20% from 1950 to 1963, when a dramatic and steady downward inflection began, arriving today at
26#
發(fā)表于 2025-3-26 01:16:32 | 只看該作者
HDLC as a therapeutic target in coronary disease: current concepts and future directions,support the concepts that HDL-related measures are as important as LDL-related ones in predicting vascular events. Furthermore, pharmacological or genetic modification of certain plasma HDL subfractions appears to hold promise for clinical benefits that are comparable to, or perhaps exceed, those of LDLC reduction.
27#
發(fā)表于 2025-3-26 05:08:55 | 只看該作者
28#
發(fā)表于 2025-3-26 09:51:21 | 只看該作者
HDL Deficiency and Atherosclerosis978-94-011-6585-3Series ISSN 0166-9842
29#
發(fā)表于 2025-3-26 13:04:37 | 只看該作者
30#
發(fā)表于 2025-3-26 17:31:39 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 21:35
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
稻城县| 抚松县| 邮箱| 桂阳县| 新绛县| 铅山县| 东乌珠穆沁旗| 凤庆县| 昌江| 景泰县| 平舆县| 鄂尔多斯市| 泸定县| 汝南县| 乡城县| 黎川县| 龙泉市| 昌宁县| 巨野县| 灌云县| 六枝特区| 岱山县| 昭通市| 宝坻区| 桓台县| 丰宁| 靖宇县| 都匀市| 曲沃县| 永兴县| 金沙县| 苍南县| 文山县| 子长县| 紫云| 浮梁县| 申扎县| 博野县| 兰考县| 瑞金市| 新泰市|